DexCom EBITDA 2011-2025 | DXCM
DexCom annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending September 30, 2025 was $0.306B, a 47.66% increase year-over-year.
- DexCom EBITDA for the twelve months ending September 30, 2025 was $1.022B, a 21.62% increase year-over-year.
- DexCom 2024 annual EBITDA was $0.818B, a 4.34% increase from 2023.
- DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
- DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
|
DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $818 |
| 2023 | $784 |
| 2022 | $547 |
| 2021 | $368 |
| 2020 | $367 |
| 2019 | $191 |
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
|
DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $306 |
| 2025-06-30 | $276 |
| 2025-03-31 | $194 |
| 2024-12-31 | $247 |
| 2024-09-30 | $207 |
| 2024-06-30 | $210 |
| 2024-03-31 | $154 |
| 2023-12-31 | $269 |
| 2023-09-30 | $254 |
| 2023-06-30 | $172 |
| 2023-03-31 | $89 |
| 2022-12-31 | $162 |
| 2022-09-30 | $187 |
| 2022-06-30 | $121 |
| 2022-03-31 | $78 |
| 2021-12-31 | $33 |
| 2021-09-30 | $144 |
| 2021-06-30 | $125 |
| 2021-03-31 | $67 |
| 2020-12-31 | $124 |
| 2020-09-30 | $113 |
| 2020-06-30 | $83 |
| 2020-03-31 | $47 |
| 2019-12-31 | $116 |
| 2019-09-30 | $69 |
| 2019-06-30 | $11 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-156 |
| 2018-09-30 | $22 |
| 2018-06-30 | $2 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $16 |
| 2017-09-30 | $4 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-37 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $4 |
| 2015-09-30 | $-40 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $4 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-10 |
| 2013-12-31 | $0 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $-9 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-15 |
| 2012-06-30 | $-13 |
| 2012-03-31 | $-14 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-12 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-11 |
| 2010-12-31 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.388B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $216.539B | 25.73 |
| Intuitive Surgical (ISRG) | United States | $206.554B | 80.81 |
| IDEXX Laboratories (IDXX) | United States | $56.662B | 56.27 |
| Edwards Lifesciences (EW) | United States | $48.792B | 32.72 |
| Alcon (ALC) | Switzerland | $36.692B | 24.63 |
| IQVIA Holdings (IQV) | United States | $36.282B | 20.23 |
| Mettler-Toledo (MTD) | United States | $29.265B | 34.24 |
| STERIS (STE) | Ireland | $25.912B | 26.75 |
| Waters (WAT) | United States | $22.419B | 29.65 |
| Hologic (HOLX) | United States | $16.526B | 17.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.655B | 0.00 |
| Globus Medical (GMED) | United States | $11.664B | 24.26 |
| Penumbra (PEN) | United States | $10.595B | 74.53 |
| Masimo (MASI) | United States | $7.762B | 24.87 |
| Sysmex ADR (SSMXY) | Japan | $6.780B | 21.54 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Teleflex (TFX) | United States | $4.772B | 7.60 |
| TransMedics (TMDX) | United States | $4.183B | 49.55 |
| Veracyte (VCYT) | United States | $3.348B | 38.15 |
| Alphatec Holdings (ATEC) | United States | $3.007B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.778B | 15.01 |
| Integer Holdings (ITGR) | United States | $2.409B | 11.31 |
| Artivion (AORT) | United States | $2.131B | 97.78 |
| Nihon Kohden (NHNKY) | Japan | $1.875B | 16.37 |
| PROCEPT BioRobotics (PRCT) | United States | $1.729B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.673B | 16.21 |
| Beta Bionics (BBNX) | United States | $1.210B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.110B | 0.00 |
| AxoGen (AXGN) | United States | $1.107B | 0.00 |
| IRadimed (IRMD) | United States | $1.095B | 52.16 |
| Pulse Biosciences (PLSE) | United States | $1.041B | 0.00 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.14 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.594B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.556B | 32.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.531B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.531B | 10.59 |
| AngioDynamics (ANGO) | United States | $0.506B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.470B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.452B | 12.47 |
| NeuroPace (NPCE) | United States | $0.448B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.443B | 3.48 |
| OrthoPediatrics (KIDS) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.416B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.345B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.332B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.312B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.47 |
| CVRx (CVRX) | United States | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.229B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.227B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Neuronetics (STIM) | United States | $0.147B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.095B | 0.00 |
| Hyperfine (HYPR) | United States | $0.081B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.39 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |